Cargando…
Clinical relevance of point mutations in the 23S rRNA gene in Helicobacter pylori eradication: A prospective, observational study
Clarithromycin-based triple therapy is prescribed worldwide for Helicobacter pylori eradication. However, increases in the clarithromycin resistance of H pylori are thought to be responsible for eradication failure. Here, we studied whether point mutations in domain V of the 23S rRNA gene can affect...
Autores principales: | Park, Chang-Geun, Kim, Seohyeon, Lee, Eun-Ju, Jeon, Hyo-Sung, Han, Seungwoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112885/ https://www.ncbi.nlm.nih.gov/pubmed/30113472 http://dx.doi.org/10.1097/MD.0000000000011835 |
Ejemplares similares
-
Validation of loop‐mediated isothermal amplification to detect Helicobacter pylori and 23S rRNA mutations: A prospective, observational clinical cohort study
por: Park, Chang‐Geun, et al.
Publicado: (2020) -
Seven-day triple therapy is sufficient to eradicate infection caused by Helicobacter pylori without 23S rRNA point mutation
por: Lee, Jung Wook, et al.
Publicado: (2021) -
Mutations in the 23S rRNA gene of Helicobacter pylori associated with clarithromycin resistance.
por: Kim, Kyung Suk, et al.
Publicado: (2002) -
A randomized controlled trial to compare Helicobacter pylori eradication rates between the empirical concomitant therapy and tailored therapy based on 23S rRNA point mutations
por: Kim, Su Jin, et al.
Publicado: (2022) -
Helicobacter pylori Eradication According to Sequencing-Based 23S Ribosomal RNA Point Mutation Associated with Clarithromycin Resistance
por: Seo, Seung In, et al.
Publicado: (2019)